NIAID Site Search

This document goes over the answers to many of the Frequently Asked Questions(FAQs) regarding the Electronic Information Systems Policy. (July 2024)

Last Reviewed: September 16, 2024

This document provides instructions for filling out Form 901 which issues a request for assignment changes.

Last Reviewed: September 12, 2024

dmid-td-pol-00002 DMID - Use of Electronic Signatures

Last Reviewed: March 12, 2025

This document provides a template for peer review appeal disposition letters.

Last Reviewed: July 11, 2024

DMID - Peripheral Blood Mononuclear Cell (PBMC) and Associated Plasma Collection

Last Reviewed: March 12, 2025

This document provides an overview of NIAID investigator-initiated program project applications (P01) including application and submission information.

Last Reviewed: May 30, 2024

DAIDS TMF Manual

Last Reviewed: January 15, 2025

Requirements for laboratories processing and testing biologic samples from participants enrolled in Division of AIDS (DAIDS)-supported clinical trials.

Last Reviewed: February 24, 2025

Policy for Laboratories Performing Testing for DAIDS Sponsored and or Supported Clinical Trials

Last Reviewed: February 24, 2025

Last Reviewed: January 15, 2025

This document lists the names and organizational affiliations of all members of NIAID Clinical Research Subcommittee (NCRS)

Last Reviewed: October 20, 2023

This document provides CRSs with guidance on the premature termination or suspension of a clinical trial.

Last Reviewed: October 2, 2023

This document provides information about Lyme disease research and how Ticks can transmit a variety of disease-causing pathogens.

Last Reviewed: October 12, 2023

Use this document to define source data and source documents practices, uses, and requirements.

Last Reviewed: March 24, 2022

This document provides additional lines for the summary of deficient key indicators (Kis) and associated criteria.

Last Reviewed: May 18, 2023

This document provides a template for writing formal letters of collaboration.

Last Reviewed: April 24, 2023

Requirements for the development of informed consent documents for Division of AIDS (DAIDS)-sponsored clinical research studies.

Last Reviewed: March 15, 2023

DAIDS requires that all CRSs have a QMS in place that defines Quality Management (QM) tools, activities, and processes to ensure work quality.

Last Reviewed: November 4, 2024

This document explains the STRIVE Shionogi research study. The study is for adults in the hospital with COVID-19 and tests the use of the investigational antiviral drug, S-217622 or ensitrelvir, when given in addition to current standard treatment.

Last Reviewed: February 2, 2023

DAIDS has a significant regulatory responsibility in the oversight of all its clinical trials.

Last Reviewed: October 30, 2024

Division of AIDS (DAIDS) Site Clinical Operations and Research Essentials (SCORE) Manual Appendix: Clinical Quality Mangement Plan: Clinical Research Site Quality Assurance Summary Report Template

Last Reviewed: October 31, 2024

This DAIDS SCORE Manual provides an overview of clinical research investigator responsibilities and related references.

Last Reviewed: October 30, 2024

This document provides an overview of research and training programs opportunities for 2022-2023 available through the Division of Intramural Research.

Last Reviewed: November 3, 2022

This document outlines systematic evaluation of nine monogenic autoinflammatory diseases.

Last Reviewed: August 8, 2022

Liu Application

Last Reviewed: November 5, 2024